NL-OMON49992招募中不适用
Target to B! - Towards patient-tailored immunotherapy to effectively treat B-cell associated disease - T2B!
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •1) subjects with a clinical syndrome fulfilling the diagnostic criteria for
- •pre-specified B-cell-related diseases; 2) disease severity requiring start of
- •anti-CD20 or antibody targeted therapy and 3) adults or children above the age
- •of 5 years.
排除标准
- •1) anti-CD20 treatment or thymectomy as part of clinical care, within the last
- •9 months ; 2) plasma exchange, plasmapheresis or immunoadsorption within the
- •last 3 months ; 3) change in the dose of general immunosuppressive or
- •oncological drugs, including azathioprine, mycophenolate mofetil, ciclosporin,
- •tacrolimus within the last 3 months (change in dose of corticosteroids or
- •intravenous immunoglobulin dose allowed); 4) anti-CD20 treatment or antibody
- •depleting therapy as part of clinical trials as based on case-based peer review
- •between researchers
研究者
相似试验
招募中
不适用
POINTING: Towards patient-tailored cancer immunotherapy supported by a multifaceted predictive signature composed of integrative omics and molecular imaging.NSCLCskin cancer (melanoma)10027476NL-OMON51740niversitair Medisch Centrum Groningen200
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
已完成
不适用
Development of a personalized immune-modulating therapy for patients with atopic dermatitis: evaluation of clinical efficacy of autologous immunoglobulin therapy for atopic dermatitis: a randomized, double-blind, placebo-controlled studyDiseases of the skin and subcutaneous tissueKCT0001597Ajou University Hospital51
尚未招募
不适用
To successfully develop novel ways of identifying Indian patients that are likely to benefit from immunotherapy for lung cancerCTRI/2022/05/042559Emory Vaccine Centre
尚未招募
1 期
A Clinical Trial to Evaluate the Effects of Autologous induced Pluripotent Stem Cell-Derived Natural Killer Cells in Personalized Treatment of Patients with Advanced Metastatic Breast CancerAdvanced Breast Cancer.Malignant neoplasm of breastIRCT20200429047241N1International Center for Personalized Medicine (ICPM)32